These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9552756)
1. Low-dose retinoid therapy for chemoprophylaxis of skin cancer in renal transplant recipients. Gibson GE; O'Grady A; Kay EW; Murphy GM J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):42-7. PubMed ID: 9552756 [TBL] [Abstract][Full Text] [Related]
2. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy. Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909 [TBL] [Abstract][Full Text] [Related]
3. Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans' cells in sun exposed and sun protected skin. Carneiro RV; Sotto MN; Azevedo LS; Ianhez LE; Rivitti EA Clin Transplant; 2005 Feb; 19(1):115-21. PubMed ID: 15659144 [TBL] [Abstract][Full Text] [Related]
4. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. De Graaf YG; Euvrard S; Bouwes Bavinck JN Dermatol Surg; 2004 Apr; 30(4 Pt 2):656-61. PubMed ID: 15061851 [TBL] [Abstract][Full Text] [Related]
5. Systemic strategies for chemoprevention of skin cancers in transplant recipients. Kovach BT; Sams HH; Stasko T Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Rook AH; Jaworsky C; Nguyen T; Grossman RA; Wolfe JT; Witmer WK; Kligman AM Transplantation; 1995 Mar; 59(5):714-9. PubMed ID: 7886798 [TBL] [Abstract][Full Text] [Related]
7. Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy. Zamanian A; Farshchian M J Drugs Dermatol; 2007 Jul; 6(7):703-6. PubMed ID: 17763593 [TBL] [Abstract][Full Text] [Related]
8. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. McKenna DB; Murphy GM Br J Dermatol; 1999 Apr; 140(4):656-60. PubMed ID: 10233316 [TBL] [Abstract][Full Text] [Related]
9. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782 [TBL] [Abstract][Full Text] [Related]
10. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. Shuttleworth D; Marks R; Griffin PJ; Salaman JR Q J Med; 1988 Sep; 68(257):717-25. PubMed ID: 3076965 [TBL] [Abstract][Full Text] [Related]
11. Use of acitretin for the skin complications in renal transplant recipients. Yuan ZF; Davis A; Macdonald K; Bailey RR N Z Med J; 1995 Jun; 108(1002):255-6. PubMed ID: 7617333 [TBL] [Abstract][Full Text] [Related]
12. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. Otley CC; Cherikh WS; Salasche SJ; McBride MA; Christenson LJ; Kauffman HM J Am Acad Dermatol; 2005 Nov; 53(5):783-90. PubMed ID: 16243126 [TBL] [Abstract][Full Text] [Related]
13. Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients. Moloney FJ; Almarzouqi E; O'Kelly P; Conlon P; Murphy GM Arch Dermatol; 2005 Aug; 141(8):978-82. PubMed ID: 16103326 [TBL] [Abstract][Full Text] [Related]
14. Melanomas in renal transplant recipients. Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778 [TBL] [Abstract][Full Text] [Related]
15. Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer. Ehdaie B; Stukenborg GJ; Theodorescu D J Urol; 2009 Oct; 182(4):1482-7. PubMed ID: 19683766 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical effects of temporary cessation of long-term acitretin treatment in keratinocytic intraepidermal neoplasia of renal transplant recipients. Blokx WA; Smit JV; de Wilde PC; van de Kerkhof PC; Ruiter DJ; de Jong EM Arch Dermatol; 2003 May; 139(5):671-3. PubMed ID: 12756113 [No Abstract] [Full Text] [Related]
17. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation. de Fijter JW Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i23-6. PubMed ID: 17456615 [TBL] [Abstract][Full Text] [Related]
18. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients. Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888 [TBL] [Abstract][Full Text] [Related]
19. Skin malignancies in renal transplant recipients: a Brazilian center registry. Falsarella PM; Alves-Filho G; Mazzali M Transplant Proc; 2008 Apr; 40(3):767-8. PubMed ID: 18455011 [TBL] [Abstract][Full Text] [Related]
20. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma. Moloney FJ; Kelly PO; Kay EW; Conlon P; Murphy GM Dermatol Surg; 2004 Apr; 30(4 Pt 2):674-8. PubMed ID: 15061854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]